Clinical Trials Browser

Thyroid Carcinoma, Anaplastic × cemiplimab × 1 year × Clear all

NCT06902376 2025-11-05

NEO-COMBATXL

Phase 1 Recruiting

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic